Perspective Therapeutics, Inc. (CATX)
5.65
0.00 (0.00%)
USD |
NYAM |
Feb 20, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Perspective Therapeutics SG&A Expense (Quarterly) : 7.731M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Abbott Laboratories | 3.129B |
| Accuray, Inc. | 18.91M |
| Alphatec Holdings, Inc. | 124.30M |
| Boston Scientific Corp. | 1.834B |
| Plus Therapeutics, Inc. | 3.443M |